Mithril Capital-led Series C to launch 5-minute noninvasive ischemia assessment requiring no pharmaceuticals, no exercise, and no radiation. MASON, Ohio–(BUSINESS WIRE)–Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing. The round was led by Mithril Capital with participation from […]
Financial
Stephen Hiscott joins Biome as Chief Revenue Officer
Health care leader brings more than a decade of senior leadership experience and a track record of growth in serving hospitals and health systems. SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leading cardiovascular performance management company, announced they have named Stephen Hiscott as Chief Growth Officer. Stephen comes to Biome from Premier, […]
Clario bolsters executive leadership team to deliver on its long-term growth strategy
New CEO appoints two new executives and promotes senior scientist to new Chief Medical Officer position to focus company and help drive delivery of long-term growth strategy Terry Burke joins Clario as Executive Vice President of Clario’s eCOA business and David Fusco as Executive Vice President of Human Capital Dr. Todd Rudo, M.D. is promoted […]
Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity
PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain to treat resistant/difficult to treat hypertension and heart-failure, today published its first half 2022 results. Jean-Philippe Milon, CEO […]
Starlight Cardiovascular Secures $9.48M in Series A Financing to Advance Pediatric Health
SAN DIEGO, Oct. 4, 2022 /PRNewswire/ — Starlight Cardiovascular announced today that it has closed the first $9.48M in an $11.45M Series A financing, which will be used to progress development of its portfolio of pediatric interventional cardiology devices. The financing is led by Bird B and included conversion of previously-issued notes. “Congenital Heart Defects are […]
Centerline Biomedical announces Gulam Khan as Chief Executive Officer
CLEVELAND, Oct. 4, 2022 /PRNewswire/ — Centerline Biomedical, Inc. (“Centerline”), which recently commercialized its Intra-Operative Positioning Systems IOPS®, has appointed Gulam Khan, Chief Executive Officer. Mr. Khan has more than two decades of executive leadership experience, including serving as the President and CEO of Mentor, Ohio-based US Endoscopy and serving as the Senior Vice […]
Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment
Award-Winning Interventional Radiologist in the NY Metro Area Adds Significant Depth and Experience HINGHAM, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), which continues to be committed to expanding its capabilities, today announced the newest appointment to its Scientific Advisory Board (SAB), David C. Madoff, M.D. […]
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on October 1, 2022 that were approved by the Compensation Committee of its Board of […]
InCarda Therapeutics Announces Execution of Planned CEO Transition to Drive Next Phase of Corporate Growth
Robert Lisicki Appointed as New Chief Executive Officer and Board Member; Possesses Broad Commercial and Public Company Experience Grace E, Colón, Ph.D., Stepping Aside Following Nearly Ten Years as President and CEO; Will Serve as Consultant to Ensure Smooth Leadership Transition SAN FRANCISCO, Oct. 04, 2022 (GLOBE NEWSWIRE) — InCarda […]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on September 30, 2022 it granted stock options to purchase an aggregate of 99,000 shares of common stock to 10 new employees, whose employment commenced in September 2022, as a material inducement to […]



